We are live on
!
Find out more
BFC
Blue Fin Capital Portfolio holdings
AUM
$692M
1-Year Est. Return
27.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$125M
AUM Growth
+$11.3M
(+9.9%)
Cap. Flow
+$5.85M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
31.83%
Holding
131
New
12
Increased
58
Reduced
39
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$503K |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$356K |
| 3 |
Accenture
ACN
|
+$331K |
| 4 |
Sturm, Ruger & Co
RGR
|
+$266K |
| 5 |
Qualcomm
QCOM
|
+$247K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$224K |
| 2 |
Southern Copper
SCCO
|
+$212K |
| 3 |
Rayonier
RYN
|
+$206K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$118K |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$98.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Healthcare | 11.23% |
| 3 | Financials | 10.05% |
| 4 | Energy | 9.77% |
| 5 | Consumer Staples | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.52T
| $8.82M | 7.07% |
379,568
+9,436
| +3% | +$201K |
|
|
2
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $6.86M | 5.49% |
72,002
+3,765
| +6% | +$356K |
|
3
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $4.43M | 3.55% |
102,441
+4,810
| +5% | +$204K |
|
4
SPDR Gold Trust
GLD
$132B
| $4.33M | 3.47% |
33,852
+1,877
| +6% | +$233K |
|
5
iShares MSCI EAFE ETF
EFA
$79.3B
| $2.76M | 2.21% |
40,400
+1,935
| +5% | +$133K |
|
6
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $2.75M | 2.2% |
68,860
+4,610
| +7% | +$182K |
|
7
ExxonMobil
XOM
$638B
| $2.71M | 2.17% |
26,947
-113
| -0.4% | -$11.4K |
|
8
Microsoft
MSFT
$3.66T
| $2.42M | 1.94% |
58,089
+3,620
| +7% | +$147K |
|
9
Berkshire Hathaway Class B
BRK.B
$1.12T
| $2.38M | 1.91% |
18,781
+310
| +2% | +$39.2K |
|
|
10
iShares Russell 3000 ETF
IWV
$20.3B
| $2.26M | 1.81% |
19,172
-870
| -4% | -$98.9K |
|
11
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $2.2M | 1.76% |
19,091
+505
| +3% | +$57.3K |
|
12
Johnson & Johnson
JNJ
$614B
| $2.19M | 1.76% |
20,963
-450
| -2% | -$45.5K |
|
|
13
Invesco Senior Loan ETF
BKLN
$6.79B
| $2.13M | 1.71% |
85,785
+20,300
| +31% | +$503K |
|
14
Alphabet (Google) Class C
GOOG
$4.59T
| $2.02M | 1.62% |
69,811
+1,114
| +2% | +$30.2K |
|
15
Chevron
CVX
$379B
| $1.98M | 1.59% |
15,185
+95
| +0.6% | +$11.8K |
|
16
Visa
V
$690B
| $1.72M | 1.38% |
32,616
+1,100
| +3% | +$57.5K |
|
17
Colgate-Palmolive
CL
$73.8B
| $1.71M | 1.37% |
25,075
+280
| +1% | +$18.8K |
|
18
GE Aerospace
GE
$391B
| $1.69M | 1.35% |
13,375
-110
| -0.8% | -$14K |
|
19
Enbridge
ENB
$117B
| $1.68M | 1.35% |
35,405
-330
| -0.9% | -$15.6K |
|
20
Mastercard
MA
$500B
| $1.67M | 1.34% |
22,725
+945
| +4% | +$70.2K |
|
21
CVS Health
CVS
$133B
| $1.6M | 1.28% |
21,208
+590
| +3% | +$44.6K |
|
22
State Street SPDR S&P Dividend ETF
SDY
$23.8B
| $1.54M | 1.23% |
20,058
+1,005
| +5% | +$75.3K |
|
23
American Express
AXP
$234B
| $1.37M | 1.1% |
14,458
+1,770
| +14% | +$160K |
|
24
Pfizer
PFE
$145B
| $1.32M | 1.06% |
46,838
+870
| +2% | +$24.8K |
|
25
Merck
MRK
$316B
| $1.31M | 1.05% |
23,808
+995
| +4% | +$54.3K |
|
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Blue Fin Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Blue Fin Capital held 131 positions worth $125M, up 9.9% from $113M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Blue Fin Capital deployed $5.85M of net new capital in Q2 2014, opening 12 new positions and adding to 58 existing holdings. Its largest new stake was Accenture: 4,125 shares worth $333K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Rayonier, an estimated $206K trimmed.
- Blue Fin Capital's largest Q2 2014 buy was Accenture: 4,125 shares worth $333K.
- Blue Fin Capital added most to Invesco Senior Loan ETF in Q2 2014, an estimated $503K increase.
- Blue Fin Capital's biggest Q2 2014 reduction was Rayonier, cutting an estimated $206K.
- Blue Fin Capital fully exited Boston Scientific in Q2 2014, selling an estimated $224K.
- Blue Fin Capital's ten largest holdings make up 32% of its $125M portfolio in Q2 2014.
- Blue Fin Capital opened 12 new positions and closed 2 in Q2 2014.
- Blue Fin Capital's portfolio value rose 9.9% quarter-over-quarter to $125M.
Based on Blue Fin Capital's 13F filing for Q2 2014, filed 29 Jul 2014.